JOYCE TITO: Open Payments
NPI 1972917649 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,377 in 150 payments from 39 companies in 2025. Trend: 2023 $1,888 · 2024 $3,730 · 2025 $3,377
Food & beverage: $3,365Education: $12
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $367 |
| E.R. Squibb & Sons, L.L.C. | 14 | $278 |
| Gilead Sciences, Inc. | 10 | $240 |
| Incyte Corporation | 10 | $231 |
| AstraZeneca Pharmaceuticals LP | 10 | $212 |
| PFIZER INC. | 9 | $209 |
| Merck Sharp & Dohme LLC | 9 | $209 |
| Janssen Biotech, Inc. | 6 | $159 |
| TerSera Therapeutics LLC | 5 | $145 |
| Daiichi Sankyo Inc. | 4 | $110 |
Products named: Trodelvy, OPDIVO, KISQALI, KEYTRUDA, Enhertu, Zoladex, JAKAFI, MONJUVI.
Industry payments across FL — which companies pay providers there.
